Treatment of kidney stone with Unani medicine Jawarish Zarooni Sada
Phase 3
- Conditions
- Health Condition 1: N200- Calculus of kidney
- Registration Number
- CTRI/2022/10/046645
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of either gender in the age group 18-65 years.
2. Patients with HasÄ?h al-Kulya (Nephrolithiasis) as diagnosed by USG (KUB) with calculi
measuring up to 5 mm (single or multiple) with or without any of the following symptoms:
Pain or heaviness in flank region
Pain or heaviness in groin/loin region
Urinary urgency
Nausea and vomiting
Exclusion Criteria
1. Size of calculi above 5 mm
2. Patients with Renal colic and Hydronephrosis
3. Patients having impacted stones
4. Previous history of stone surgery
5. Patients with signs of renal failure
6. Pregnant and lactating women
7. Known cases of Hepatic, Renal or Cardiac ailments
8. Patients having systemic disease requiring long term treatment like Diabetes mellitus,
Hypertension etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The efficacy of the drug will be assessed on the basis of following parameters: <br/ ><br>1. Clinical Parameters i.e. Reduction in signs and symptoms. <br/ ><br>2. Radiological Parameters- Ultrasound KUB will be taken as criteria for detection of reduction in stone size or expulsion of stone. <br/ ><br>3. Frequency of Rescue medication used during the protocol duration. <br/ ><br>4. Classical Examination of Urine (Nazri Muana-e-Bawl)Timepoint: At baseline, 2, 4, 6 and 8 weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: At baseline, 4 and 8 weeks